Back
Bicara Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
BCAX
Bicara Therapeutics
Last Price:
18.08
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Bicara Therapeutics Price Quote
$18.08
-0.01 (1.74%)
(Updated: November 23, 2024 at 3:46 PM ET)
Bicara Therapeutics Key Stats
Sell
20
Bicara Therapeutics (BCAX)
is a Sell
Day range:
$17.51 - $18.72
52-week range:
$17.41 - $28.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
415.1K
Avg. volume:
336.6K
1-year change:
0%
Market cap:
$832.6M
Revenue:
$0
EPS:
$-0.2
How Much Does Bicara Therapeutics Make?
Data Unavailable
Is Bicara Therapeutics Growing As A Company?
Data Unavailable
Bicara Therapeutics Stock Price Performance
-
Did Bicara Therapeutics Stock Go Up Last Month?
Bicara Therapeutics share price went down by -20.17% last month -
Did BCAX's Share Price Rise Over The Last Year?
BCAX share price rose by 0% over the past 1 year
What Is Bicara Therapeutics 52-Week High & Low?
-
What Is Bicara Therapeutics’s 52-Week High Share Price?
Bicara Therapeutics has traded as high as $28.09 over the past 52 weeks -
What Is Bicara Therapeutics’s 52-Week Low Share Price?
Bicara Therapeutics has traded as low as $17.41 over the past 52 weeks
Bicara Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bicara Therapeutics?
-
How Much Debt Does Bicara Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Bicara Therapeutics Have?
Cash and short term investments quarterly total is $203.9M -
What Is Bicara Therapeutics’s Book Value Per Share?
Book value per share is -3.80
Is Bicara Therapeutics Cash Flow Positive?
-
What Is BCAX Cash Flow From Operations?
Cash flow from operations (TTM) is -$46.1M -
What Is Bicara Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $235.5M -
What Is Bicara Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$547K
Bicara Therapeutics Return On Invested Capital
Data Unavailable
Bicara Therapeutics Earnings Date & Stock Price
-
What Is Bicara Therapeutics's Stock Price Today?
A single share of BCAX can be purchased today for 18.09 -
What Is Bicara Therapeutics’s Stock Symbol?
Bicara Therapeutics trades on the nasdaq under the ticker symbol: BCAX -
When Is Bicara Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Bicara Therapeutics is scheduled on February 28, 2025 -
When Is BCAX's next ex-dividend date?
Bicara Therapeutics's next ex-dividend date is November 24, 2024 -
How To Buy Bicara Therapeutics Stock?
You can buy Bicara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bicara Therapeutics Competitors
-
Who Are Bicara Therapeutics's Competitors?
Below is a list of companies who compete with Bicara Therapeutics or are related in some way:
Bicara Therapeutics Dividend Yield
-
What Is BCAX Dividend Yield?
Bicara Therapeutics’s dividend yield currently is 0% -
What Is Bicara Therapeutics’s Payout Ratio?
Bicara Therapeutics’s payout ratio is 0% -
When Did Bicara Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is Bicara Therapeutics’s Dividend Per Share?
Bicara Therapeutics pays a dividend of $0.00 per share
Bicara Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -220% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 40.06 |
| Upside from Last Price: | 121.47% |